• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Medtronic Ireland EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Medtronic Ireland EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number D-EVOLUTFX-2329
Medical Device Problem Codes Failure to Advance (2524); Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Vascular Dissection (3160)
Date of Event 07/28/2026
Type of Reportable Event Serious Injury
Event or Problem Description
Additional information was received indicating that the injury occurred during insertion and advancement.It was reported that the non-medtronic sheath was passed through the stenosed/dissected area and that the delivery catheter system (dcs) never passed though it.Dissection was not confirmed.Per the physician, the cause of the injury was unknown.It was noted that the minimum diameter of the access vessel was 5 millimeter (mm) x 6mm.
 
Event or Problem Description
It was reported that during a transcatheter aortic valve implant procedure, the delivery catheter system (dcs) was inserted into the patient's right femoral artery.There was then difficulty in advancing the catheter within the patient's right femoral artery.Subsequently, a balloon angioplasty was completed of the right femoral artery and external iliac artery.A possible dissection was then noted.Per the physician, the patient's calcified anatomy contributed to the event.
 
Additional Manufacturer Narrative
Updated: b5 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Continuation of d10: product id evfxplus-26 (serial: (b)(6)); product type: 0195-heart valves; implant date: n/a ; explant date: n/a medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX DCS
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
Medtronic Ireland
parkmore business park west
galway
EI 
Manufacturer (Section G)
Medtronic Ireland
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
+353(091)708096
MDR Report Key50077991
Report Number9612164-2026-03837
Device Sequence Number13450220
Product Code NPT
UDI-Device Identifier00763000365677
UDI-Public(01)00763000365677(17)270102(10)0012606112
Combination Product (Y/N)N
Initial Reporter StateND
Initial Reporter CountryUS
PMA/510(K) Number
P130021
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/15/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberD-EVOLUTFX-2329
Device Catalogue NumberD-EVOLUTFX-2329
Device Lot Number0012606112
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/28/2026
Supplement Date Received by Manufacturer07/30/2026
09/07/2026
Initial Report FDA Received Date07/30/2026
Supplement Report FDA Received Date08/27/2026
09/15/2026
Date Device Manufactured01/02/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11...
Outcome Attributed to Adverse Event Required Intervention;
Patient Age76 YR
Patient SexFemale
-
-